The epidermal growth factor receptor (EGFR), which is overexpressed in up to 60% of ovarian cancers [19], upregulates expression of c-Myc and cyclin D1, promoting both aerobic glycolysis and cell cycle progression [20]. Here, CCND1 is linked to ovarian cancer.